The 2024 Canadian Cancer Statistics project provides projections for new cancer cases and deaths in Canada. It estimates that 247,100 new cancer cases and 88,100 cancer deaths will occur in 2024. The age-standardized incidence rate (ASIR) and mortality rate (ASMR) are expected to slightly decrease for both males and females, with higher rates among males. Common cancers like lung, colorectal, and prostate are projected to see continued declines in incidence and mortality, while others such as liver and intrahepatic bile duct cancer, kidney cancer, melanoma, and non-Hodgkin lymphoma are expected to increase. The overall impact of cancer on Canadian health systems is significant, with cancer being the leading cause of death in the country. The study highlights the need for continued investment in cancer prevention, screening, and treatment to reduce the burden of cancer on Canadians. The projections are based on data from the Canadian Cancer Registry and Vital Statistics Death Database, and use statistical models to estimate future trends. The study also notes that cancer incidence and mortality have been declining over time, but the growing and aging population is expected to increase the number of new cancer cases and deaths in 2024. The study emphasizes the importance of addressing the social determinants of cancer and improving cancer care to reduce the impact of cancer on Canadians. The findings are based on data from 1984 to 2020 and projections for 2024. The study was conducted by the Canadian Cancer Statistics Advisory Committee in collaboration with Statistics Canada, the Public Health Agency of Canada, and the Canadian Cancer Society. The study was peer-reviewed and funded by public and donor funding. The data used in the study are available to the public and researchers through Statistics Canada's Research Data Centres. The findings and conclusions are those of the authors and do not necessarily represent the official position of the Canadian Cancer Society.The 2024 Canadian Cancer Statistics project provides projections for new cancer cases and deaths in Canada. It estimates that 247,100 new cancer cases and 88,100 cancer deaths will occur in 2024. The age-standardized incidence rate (ASIR) and mortality rate (ASMR) are expected to slightly decrease for both males and females, with higher rates among males. Common cancers like lung, colorectal, and prostate are projected to see continued declines in incidence and mortality, while others such as liver and intrahepatic bile duct cancer, kidney cancer, melanoma, and non-Hodgkin lymphoma are expected to increase. The overall impact of cancer on Canadian health systems is significant, with cancer being the leading cause of death in the country. The study highlights the need for continued investment in cancer prevention, screening, and treatment to reduce the burden of cancer on Canadians. The projections are based on data from the Canadian Cancer Registry and Vital Statistics Death Database, and use statistical models to estimate future trends. The study also notes that cancer incidence and mortality have been declining over time, but the growing and aging population is expected to increase the number of new cancer cases and deaths in 2024. The study emphasizes the importance of addressing the social determinants of cancer and improving cancer care to reduce the impact of cancer on Canadians. The findings are based on data from 1984 to 2020 and projections for 2024. The study was conducted by the Canadian Cancer Statistics Advisory Committee in collaboration with Statistics Canada, the Public Health Agency of Canada, and the Canadian Cancer Society. The study was peer-reviewed and funded by public and donor funding. The data used in the study are available to the public and researchers through Statistics Canada's Research Data Centres. The findings and conclusions are those of the authors and do not necessarily represent the official position of the Canadian Cancer Society.